HealthMore in Health →
New Urine Test May Reduce Biopsies for Men on Prostate Cancer Surveillance
A study in The Journal of Urology found that the MPS2-AS urine test outperformed PSA-based testing and MRI for monitoring low-risk prostate cancer and could help avoid many unnecessary repeat biopsies.
Key Takeaways
- A study found the MPS2-AS urine test performed better than PSA-based testing and MRI for active surveillance.
- The test could have avoided up to 64% of unnecessary repeat biopsies in the studied group.
DE
DT Editorial AI··via medicalxpress.com
